Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Alessandra Piona"'
Autor:
Giovanni Paoletti, Jack Pepys, Maria Chiara Bragato, Sandro Paoletti, Alessandra Piona, Maria Rita Messina, Francesca Racca, Sebastian Ferri, Emanuele Nappi, Giovanni Costanzo, Lorenzo Del Moro, Francesca Puggioni, Giorgio Walter Canonica, Elena Azzolini, Enrico Heffler
Publikováno v:
Vaccines, Vol 11, Iss 5, p 903 (2023)
The anti-SARS-CoV-2 vaccination has probably been the most effective tool for preventing the infection and negative outcomes of the COVID-19 disease, and therefore for interrupting the pandemic state. The first licensed SARS-CoV-2 vaccine was BNT162b
Externí odkaz:
https://doaj.org/article/0ab7fc91a1284912bdec0f007f11bed4
Autor:
Emanuele Nappi, Francesca Racca, Alessandra Piona, Maria Rita Messina, Sebastian Ferri, Donatella Lamacchia, Giuseppe Cataldo, Giovanni Costanzo, Lorenzo Del Moro, Francesca Puggioni, Giorgio Walter Canonica, Enrico Heffler, Giovanni Paoletti
Publikováno v:
Vaccines, Vol 11, Iss 5, p 915 (2023)
Concern has arisen about hypersensitivity reactions in patients with allergic reactions to drugs containing polyethylene glycol (PEG) or polysorbate 80 (PS80), excipients of currently available anti-SARS-CoV-2 mRNA vaccines. However, the actual utili
Externí odkaz:
https://doaj.org/article/dbd77063965141f4b12cbfb5049101a6
Autor:
Giovanni Paoletti, Francesca Racca, Alessandra Piona, Giulio Melone, Morena Merigo, Francesca Puggioni, Sebastian Ferri, Elena Azzolini, Michele Lagioia, Donatella Lamacchia, Giuseppe Cataldo, Maurizio Cecconi, Giorgio Walter Canonica, Enrico Heffler
Publikováno v:
World Allergy Organization Journal, Vol 14, Iss 5, Pp 100541- (2021)
Background: Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccines have been approved recently, and public concern regarding the risk of anaphylactic reactions arose after a few cases during the first days of mass vaccination. Po
Externí odkaz:
https://doaj.org/article/9e6ee3c7b9f7486bb8644218666ad052
Autor:
Morena Merigo, Michele Lagioia, Giorgio Walter Canonica, Giuseppe Cataldo, Francesca Puggioni, Donatella Lamacchia, Giulio Melone, Francesca Racca, Maurizio Cecconi, Enrico Heffler, Alessandra Piona, Elena Azzolini, Sebastian Ferri, Giovanni Paoletti
Publikováno v:
The World Allergy Organization Journal
World Allergy Organization Journal, Vol 14, Iss 5, Pp 100541-(2021)
World Allergy Organization Journal, Vol 14, Iss 5, Pp 100541-(2021)
Background Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccines have been approved recently, and public concern regarding the risk of anaphylactic reactions arose after a few cases during the first days of mass vaccination. Pol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81f9a9bcb3731c4a9ea4d55c06970b1e
http://europepmc.org/articles/PMC8030995
http://europepmc.org/articles/PMC8030995